

Clinical Data Management leader with over 20 years of experience in developing and managing global CDM and biometrics teams within CRO and hybrid service models. Expertise in overseeing comprehensive CDM delivery for large, complex portfolios while enhancing operational efficiency and profitability. Recognized for establishing high-performing leadership structures and modernizing CDM operations through process standardization and advanced analytics. Demonstrates effective leadership in complex environments, aligning CDM functions with organizational growth objectives.
As Service Delivery Lead, I directed global data and study operations across approximately 95 clinical trials in oncology, cell therapy, and early development for BMS, leading an organization of approximately 220 professionals and 12 direct reports. Acted as a senior strategic partner to the client, participating in executive governance, delivery reviews, and transformation discussions.
• Global Study Management: Oversaw end-to-end trial delivery, ensuring on-time, within-budget completion aligned to BMS’s R&D goals. Owned department-level delivery strategy, KPIs, and operating rhythms across regions.
• Operational Governance: Implemented unified CDM operating models, established portfolio governance and escalation frameworks, project health dashboards, and study risk monitoring systems, driving transparency and proactive issue resolution.
• Leadership & Talent Development: Built a robust leadership pipeline through mentoring, performance management, and succession planning. Drove talent engagement and inclusion initiatives recognized at the enterprise level. Established competency frameworks, onboarding programs, therapeutic academies, and leadership development initiatives for CDM and delivery leaders.
• Transformation & Process Excellence: Spearheaded delivery optimization programs, reducing overall cycle times by 12%, and standardizing SOPs across therapeutic areas.
• Financial Management:
Led commercial delivery management, including forecasting, utilization optimization, and margin protection through efficient resourcing and execution. Ensured sustained portfolio profitability.
• Recognition: Recipient of multiple leadership and client excellence awards; selected as a Mental Wellness Advocate Coach and Inclusion & Diversity Champion.
Held progressive leadership roles overseeing global delivery for Janssen and AstraZeneca portfolios, with team sizes of up to 120. Managed complex oncology and immunology portfolios, ensuring strategic alignment, operational consistency, and quality. Oversaw end-to-end CDM operations, including study start-up, data cleaning, database locks, quality oversight, audits, and inspection readiness.